Elevance Health, US0367521038

Elevance Health stock after-hours at EUR 363.40: plus 2.44 percent

Published on 10/07/2026 at 21:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At 9:07 p.m. CEST on October 7, 2026, Elevance Health was at EUR 363.40 in after-hours trading at Lang & Schwarz. The stock was up plus 2.44 percent against the October 6 reference close.

Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte US2855211023 und Stethoskop
Elevance Health US2855211023 Flatlay mit Aktienzertifikat ISIN-Karte Stethoskop und medizinischen Utensilien auf Marmor, Illustration mit AI erstellt.

Elevance Health stock was at EUR 363.40 in after-hours trading at Lang & Schwarz at 9:07 p.m. CEST on October 7, 2026, up plus 2.44 percent versus the prior close of EUR 354.75 on October 6, 2026. The quote showed a bid of EUR 362.70 and an ask of EUR 364.10.

Trading after the Xetra close

The euro indication was recorded after Xetra’s 5:30 p.m. close and during the after-hours period at Lang & Schwarz. The timestamp places the quote within the evening trading session for investors in Germany. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.

Scheduled third-quarter report

On October 5, 2026, Business Wire reported that Elevance Health, listed on the NYSE under ELV, plans to release third-quarter 2026 results on October 21 at 6:00 a.m. EDT and hold a management conference call at 8:30 a.m. EDT, with a webcast replay available through November 20. The release said the company’s businesses serve approximately 104 million consumers across medical, pharmacy, behavioral, clinical, home health and complex care solutions.

More news and analysis on Elevance Health stock

Disclaimer...

en | US0367521038 | ELEVANCE HEALTH | boerse | 70259237 | bgmi